Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 8/20 | 0.71 |
| ▸ | SCN3A | Q9NY46 | 11/20 | 0.55 |
| ▸ | SCN1A | P35498 | 1/20 | 0.55 |
| ▸ | SCN4A | P35499 | 1/20 | 0.55 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.55 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.55 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.55 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.55 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.55 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 4/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.49 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.49 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.49 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL312070 | 0.92 | KCNH2 (0.72) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| SCHEMBL20886464 | 0.83 | KCNH2 (0.77) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| SCHEMBL2839975 | 0.83 | KCNH2 (1.00) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| SCHEMBL2712355 | 0.82 | KCNH2 (0.76) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| Hydrochloric Acid SCHEMBL2836853 | 0.82 | KCNH2 (0.98) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| SCHEMBL2712421 | 0.82 | KCNH2 (0.76) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| SCHEMBL2714986 | 0.82 | KCNH2 (0.76) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| Hydrochloric Acid SCHEMBL483682 | 0.82 | KCNH2 (0.74) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| SCHEMBL24491222 | 0.78 | KCNH2 (0.71) | KCNH2SCN3ASCN1ASCN4ASCN7A | |
| SCHEMBL22546665 | 0.78 | KCNH2 (0.71) | KCNH2SCN3ASCN1ASCN4ASCN7A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200147041-A1 | PAROXYSMAL EXTREME PAIN DISORDER TREATMENT | Convergence Pharmaceuticals Limited (GB) | 2020-05-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200147041-A1 | PAROXYSMAL EXTREME PAIN DISORDER TREATMENT | PEPD, FAP, PREP | KCNH2 348/4885SCN3A 17/4885SCN1A 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.